Home

MPM BIOVENTURES III GMBH & CO. Beteiligungs KG

CIK 1249133 · last filed 2016-09-29

MPM BIOVENTURES III GMBH & CO. Beteiligungs KG is a corporate insider who has filed 6 SEC Form 4 insider transactions across 5 companies since 2007. The most recent filing, for RDUS, was dated Sep 29, 2016. Across all open-market trades the lifetime net is +$30.4M, making them a net buyer over the disclosed history. The firm reports its address in Boston, MA. 40 SEC filings were submitted jointly with MICHAEL STEINMETZ.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

5

Total Filings

6

Lifetime Open-Market Net

$30.38M

Filer Profile

Reported Address
THE JOHN HANCOCK TOWER
200 CLARENDON STREET, 54TH FLOOR
BOSTON, MA 02116
Phone
(617) 425-9200
State of Incorporation
Germany
Formerly Known As
MPM BIOVENTURES III GMBH & CO (2004–2005)
MPM BIO VENTURES III GMBH & CO (2003–2003)
Related Filers
MICHAEL STEINMETZ — 40 joint filings, latest 2016-09-29
KURT WHEELER — 34 joint filings, latest 2007-01-10
NICHOLAS GALAKATOS — 32 joint filings, latest 2007-01-10
MPM ASSET MANAGEMENT LLC — 12 joint filings, latest 2011-10-28
DENNIS HENNER — 6 joint filings, latest 2016-09-29
ANSBERT GADICKE — 4 joint filings, latest 2005-04-28
LUKE EVNIN — 3 joint filings, latest 2005-04-28
MPM Bio IV NVS Strategic Fund LP — same reported address
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
Radius Health, Inc. (RDUS) Delisted 2,459,804 $30.00 $73.79M $0 1 2016-09-29
HUMANIGEN, INC (KBIO) Delisted 10%+ Owner 2,319,401 — — $0 1 2013-02-07
ReShape Weightloss Inc. (ETRM) Delisted 1,669,753 — — $0 1 2010-12-15
Pernix Sleep, Inc. (SOMX) Delisted 10%+ Owner 579,070 — — $9.38M 1 2009-07-09
HELICOS BIOSCIENCES CORP (HLCS) Delisted 10%+ Owner 1,162,836 — — $21.00M 1 2007-05-31

Recent Filings

6 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2016-09-29 Radius Health, Inc. (RDUS) Delisted Other (J) −11,069,118 $0 EDGAR
2013-02-07 HUMANIGEN, INC (KBIO) Delisted Conv (C) +21,063,424 $0 EDGAR
2011-10-28 — Sell (S) −5,910,456 -$6.09M
2010-12-15 ReShape Weightloss Inc. (ETRM) Delisted Conv (C) +4,932,249 $0 EDGAR
2009-07-09 Pernix Sleep, Inc. (SOMX) Delisted Buy (P) +8,936,151 $9.38M EDGAR
2007-05-31 HELICOS BIOSCIENCES CORP (HLCS) Delisted Mixed +20,914,383 $21.00M EDGAR
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.